[Genetic diagnosis of hyperlipidemia--polymorphism and variant].
Tsukamoto
K
K
Department of Metabolic Disease, Faculty of Medicine, Tokyo University.
D001055:Apolipoproteins B / Q000235:genetics; D001057:Apolipoproteins E / Q000235:genetics; D002352:Carrier Proteins / Q000235:genetics; D053480:Cholesterol Ester Transfer Proteins; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D014644:Genetic Variation; D006023:Glycoproteins; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics*; D008071:Lipoprotein Lipase / Q000235:genetics; D009363:Neoplasm Proteins; D011110:Polymorphism, Genetic; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics; D011973:Receptors, LDL / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics; D025521:Tumor Suppressor Proteins
D001055:Apolipoproteins B; D001057:Apolipoproteins E; C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; C107608:FABP7 protein, human; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D006023:Glycoproteins; D009363:Neoplasm Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D011973:Receptors, LDL; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C106092:microsomal triglyceride transfer protein; D008071:Lipoprotein Lipase